[go: up one dir, main page]

MX2012010520A - Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales. - Google Patents

Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales.

Info

Publication number
MX2012010520A
MX2012010520A MX2012010520A MX2012010520A MX2012010520A MX 2012010520 A MX2012010520 A MX 2012010520A MX 2012010520 A MX2012010520 A MX 2012010520A MX 2012010520 A MX2012010520 A MX 2012010520A MX 2012010520 A MX2012010520 A MX 2012010520A
Authority
MX
Mexico
Prior art keywords
oxidative stress
treatment
antioxidant composition
reducing oxidative
hormonal contraceptive
Prior art date
Application number
MX2012010520A
Other languages
English (en)
Other versions
MX342417B (es
Inventor
Umberto Cornelli
Original Assignee
Cor Con Internat S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Con Internat S R L filed Critical Cor Con Internat S R L
Publication of MX2012010520A publication Critical patent/MX2012010520A/es
Publication of MX342417B publication Critical patent/MX342417B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describe una composición antioxidante para reducir el estrés oxidativo en sujetos que se someten a tratamiento con fármaco anticonceptivo hormonal; en particular, dicha composición ha demostrado ser especialmente conveniente ya que, además de ser sorprendentemente efectiva, es extremadamente bien tolerada por el cuerpo ya que contiene componentes naturales tales como catequinas del té verde, levadura de selenio, ácido alfalipoico, y coenzima Q10.
MX2012010520A 2010-03-12 2011-03-11 Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales. MX342417B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10425067A EP2364697A1 (en) 2010-03-12 2010-03-12 Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs
PCT/EP2011/053680 WO2011110661A1 (en) 2010-03-12 2011-03-11 Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs

Publications (2)

Publication Number Publication Date
MX2012010520A true MX2012010520A (es) 2013-01-18
MX342417B MX342417B (es) 2016-09-27

Family

ID=42537475

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012010520A MX342417B (es) 2010-03-12 2011-03-11 Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales.

Country Status (8)

Country Link
US (1) US20130251696A1 (es)
EP (2) EP2364697A1 (es)
JP (1) JP5852971B2 (es)
CN (1) CN102811714B (es)
AU (1) AU2011226037B2 (es)
ES (1) ES2587255T3 (es)
MX (1) MX342417B (es)
WO (1) WO2011110661A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2567695B1 (en) * 2011-09-09 2016-10-26 Cornelli Consulting S.A.S. Di Umberto Cornelli & C. Antioxidant composition for reducing oxidative stress ascribable to treatment with hormonal contraceptives
ITMI20130397A1 (it) * 2013-03-15 2014-09-16 Giuliani Spa Composizione a base di flavonidi per uso farmaceutico, nutrizionale o cosmetico con potenziata azione antiossidante
JP6771853B2 (ja) * 2014-03-31 2020-10-21 小林製薬株式会社 ビタミンｂ６含有組成物
RU2563178C1 (ru) * 2014-07-11 2015-09-20 государственное бюджетное образовательное учреждение высшего профессионального образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО ТюмГМУ Минздрава России) Способ профилактики оксидативного стресса на фоне применения гормональной контрацептивной рилизинг-системы
CA2965671A1 (en) * 2014-10-24 2016-04-28 Robert Shorr Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
JP7795755B2 (ja) * 2020-04-17 2026-01-08 共栄化学工業株式会社 皮膚外用剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1072265A1 (en) * 1999-07-20 2001-01-31 MEDIS S.r.l. Medical Infusion Systems Use of plant polyphenols for treating iron overload
US20050053560A1 (en) * 2003-09-05 2005-03-10 Pharmaton S.A Use of a composition containing extracts of Vitis vinifera and lycopersicum for protecting the skin
US20100129467A9 (en) * 2007-08-31 2010-05-27 Albritton Iv Ford D Nutritional supplement
CN101433314B (zh) * 2007-11-13 2012-05-30 蒋爱芳 一种具有抗疲劳、抗氧化功能的保健食品
KR101388395B1 (ko) * 2008-01-10 2014-04-22 뉴트리 가부시키가이샤 고령자의 영양 상태 개선, 발열 횟수의 저하 및/또는 면역능 향상을 위한 조성물
GB0802403D0 (en) * 2008-02-08 2008-03-12 Probiox Sa Compositions for the treatment of oxidative stress
CN101569414B (zh) * 2008-04-29 2013-04-10 安琪酵母股份有限公司 一种富含酵母硒和酵母葡聚糖的组合物

Also Published As

Publication number Publication date
US20130251696A1 (en) 2013-09-26
MX342417B (es) 2016-09-27
JP5852971B2 (ja) 2016-02-03
AU2011226037B2 (en) 2014-11-27
EP2544675A1 (en) 2013-01-16
WO2011110661A1 (en) 2011-09-15
ES2587255T3 (es) 2016-10-21
JP2013522262A (ja) 2013-06-13
CN102811714A (zh) 2012-12-05
EP2544675B1 (en) 2016-06-01
EP2364697A1 (en) 2011-09-14
CN102811714B (zh) 2016-08-03
AU2011226037A1 (en) 2012-10-11

Similar Documents

Publication Publication Date Title
HK1211231A1 (en) Exendin-4 derivatives
GB2491327A (en) Delayed prolonged drug delivery
GB2491328A (en) Immediate/delayed drug delivery
WO2010083239A3 (en) Therapeutic modulation of vaginal epithelium boundary lubrication
PH12015500688A1 (en) Exendin-4 derivatives as dual glp1/glucagon agonists
MX2011007702A (es) Composiciones farmaceuticas que comprenden imidazoquinolin(aminas) y derivados de las mismas apropiados para administraccion local.
IN2015DN02729A (es)
WO2011069010A3 (en) Amantadine compositions and methods of use
MX342417B (es) Composicion antioxidante para reducir el estres oxidativo atribuible al tratamiento con farmacos anticonceptivos hormonales.
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2012142413A3 (en) Nitrite compositions and uses thereof
PH12013501902A1 (en) Infant formula for use in the prevention of cardiovascular diseases
MX342947B (es) Tratamiento de diabetes tipo 2.
MX2014001393A (es) 3-(bifenil-3-il)-4-hidroxi-8-metoxi-1-azaespiro[4.5]dec-3-en-2-on as sustituidas.
MX2011011559A (es) Parasiticidas sanguineos.
IN2014DN09383A (es)
WO2012105816A3 (ko) 새콩 분말 또는 이의 추출물을 포함하는 당뇨병 및 당뇨합병증 예방 및 치료를 위한 조성물
MX336154B (es) Tratamiento de atrofia vaginal en mujeres con riesgo de patologia tumoral.
WO2013188876A3 (en) Methods for modulating kallikrein (klkb1) expression
WO2014031745A3 (en) Materials and methods for modulating glucose uptake
MY159675A (en) Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
RU2012155738A (ru) Композиция антиоксидантного состава, направленного на подавление окислительного стресса при диабете 2 типа
RU2012137549A (ru) Композиция внутреннего применения для коррекции гормонального старения кожи
WO2011099721A3 (ko) 수지상 세포의 성숙화 유도용 조성물
UA56675U (ru) Способ местного лечения генерализованного пародонтита c использованием синглетно-кислородной терапии

Legal Events

Date Code Title Description
FG Grant or registration